0.00
Schlusskurs vom Vortag:
$0.048
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$3.45M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-88.35M
KGV:
0.00
EPS:
-1.3391
Netto-Cashflow:
$-81.07M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
Io Biotech Inc Stock (IOBT) Company Profile
Firmenname
Io Biotech Inc
Sektor
Branche
Telefon
(457) 070-2980
Adresse
OLE MAALOES VEH 3, COPENHAGEN
Compare IOBT vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
IOBT
Io Biotech Inc
|
0.00 | 3.45M | 0 | -88.35M | -81.07M | -1.3391 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.93 | 112.92B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
612.14 | 64.18B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
893.52 | 55.57B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
282.85 | 37.76B | 4.29B | 577.22M | 641.34M | 4.2086 |
|
RVMD
Revolution Medicines Inc
|
153.87 | 32.71B | 742.00K | -1.37B | -1.07B | -7.0731 |
Io Biotech Inc Stock (IOBT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-26 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2026-01-08 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-09-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-30 | Herabstufung | TD Cowen | Buy → Hold |
Io Biotech Inc Aktie (IOBT) Neueste Nachrichten
IO Biotech (IOBT) common stock removed from Nasdaq in voluntary withdrawal - Stock Titan
Layoff Tracker: Fulcrum axes 85% of staff after walking away from lead asset - BioSpace
Fierce Biotech Layoff Tracker 2026: Fulcrum cuts 85% of staff; Novartis trims research team - Fierce Biotech
Major IO Biotech (IOBT) shareholder updates 27.4% stake as company enters Chapter 7 - Stock Titan
IOBTQ Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
IO Biotech (IOBT) Holds Steady at $0.05 as Key Support and Resistance ConvergeTrend Continuation Trade - The Legal Advocate
IO Biotech Q3 2025 Earnings: EPS Beat of 60.67% Surprise, but No Revenue from Pre-Commercial PipelineEstimate Revision Count - The Legal Advocate
IO Biotech Inc. (IOBT) Hovers at $0.05 as Trading Activity Remains SubduedGamma Flip Level - The Legal Advocate
Finanzdaten der Io Biotech Inc-Aktie (IOBT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):